Maja J.A. de Jonge

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

Daphne van der Velden, Louisa R. Hoes, Hanneke van der Wijngaart et al. · Nature · 2019 · 252 citations · Full text

Drug Repositioning, Oncology, Preclinical Drug Evaluation +11

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg et al. · Nature Medicine · 2023 · 252 citations · Full text

Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors

Ferry A.L.M. Eskens, Francisco Javier Ramos, Herman Burger et al. · Clinical Cancer Research · 2013 · 246 citations · Full text

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma

J M W van Haarst, Paul Baas, C. Manegold et al. · British Journal of Cancer · 2002 · 158 citations · Full text

Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia

Jessica M. van der Bol, Ron H.J. Mathijssen, Walter J. Loos et al. · Journal of Clinical Oncology · 2007 · 126 citations · Full text